News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioject Medical Technologies Inc. (BJCT): Two Separate Studies Presented at the AIDS Vaccine 2007 Conference Show Improved Results with the Biojector(R)2000


8/22/2007 9:41:38 AM

PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Nasdaq:BJCT), a leading developer of needle-free drug delivery systems, today reported results from two studies presented at the AIDS Vaccine 2007 Conference in Seattle, Washington, which showed significantly improved results when the Biojector®2000 (“B2000”) needle-free system is used for the delivery of DNA vaccines.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES